In the BioHarmony Drug Report Database
Amlexanox, Aphthasol (amlexanox) is a small molecule pharmaceutical. Amlexanox was first approved as Amlexanox on 1996-12-17. It is used to treat atopic dermatitis, rhinitis, and ulcer in the USA. It is known to target serine/threonine-protein kinase TBK1 and inhibitor of nuclear factor kappa-B kinase subunit epsilon.
Image (chem structure or protein)